Cipla launches Cipremi, likely to price it Rs 4,000 per vial
It is looking to supply over 80,000 vials within the first month
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Premas Biotech initiates triple antigen VLP COVID-19 vaccine candidate for animal trials
At the moment, it is the only one from India to adopt a triple-antigen approach that is designed to produce an enhanced immune…
Pharma firms initiate steps to curb black marketing of remedisivir
Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with…
Blueprint for self-reliance in the bio-pharma sector
Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals highlights that the COVID-19 crisis has opened a window of opportunity…
Doctors view ‘antiviral agents’ as the most effective therapeutic option for treating COVID-19:…
Anti-inflammatory drugs, convalescent plasma therapy are opined to be the next-best treatments; AI, ML, Big Data and IoT emerge as…
China’s Sinovac starts late stage trials for its COVID-19 vaccine
Moderna also plans to start its late-stage trial this month
Serum Institute of India expects COVID vaccine by year-end
He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate…
WHO acknowledges ‘evidence emerging’ of airborne spread of COVID-19
The WHO has previously said the virus that causes the COVID-19 respiratory disease spreads primarily through small droplets…
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against…
In collaboration with Laxai Life Sciences, it aims to determine the safety and efficacy of three combination drugs…
‘At war time speed’, China leads COVID-19 vaccine race
Sinovac Biotech’s experimental vaccine set to become the country’s second and the world’s third to enter final stage testing later…